Stamford Covid patients to benefit from new drug therapy
It will help high risk patients who need extra help to fight Covid-19
A new drug therapy to help those at highest risk from Covid-19 infection has been offered to the first patients by the NHS Trust which runs Stamford Hospital.
North West Anglia NHS Foundation Trust is administering the drug in a specialist clinic.
Sotrovimab provides a one-off 50ml infusion of antibodies to clinically-vulnerable patients who have tested positive for Covid-19 and are within the first five days of infection.
Dr Kanchan Rege, Chief Medical Officer at North West Anglia NHS Foundation Trust, which runs Peterborough City, Hinchingbrooke and Stamford Hospitals, said: “At the time we set up our clinic, it was the only one to do so in Cambridgeshire. Cambridge University Hospitals is now assisting us, but it has been a real coup for us to commence the clinic and support some of our most vulnerable patients.
“The type of patients who are benefitting from this therapy include those on immunosuppressants or chemotherapy, in other words, people who require extra help to defend themselves against Covid-19.
“While this is a relatively small patient group, it is really important for us to be able to help them avoid developing complications and needing admission to hospital.
“I’d like to thank all the team involved in setting up the clinic at a time when our hospitals have also been under pressure.”